Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis
Completed · Phase 4 · Has a placebo group
Conditions studied: Rheumatoid Arthritis
In brief
This study is designed to evaluate the efficacy and safety of tofacitinib modified release formulation (11mg QD) versus tofacitinib modified release formulation plus continued methotrexate treatment in subjects with moderate to severe rheumatoid arthritis who are insufficiently responding to their stable dose of methotrexate treatment.
Key facts
- Study ID
- NCT02831855
- Run by
- Pfizer
- People needed
- 694
- Starts
- 2016-09-01
- Expected to finish
- 2018-12-17
- Last updated by the study team
- 2019-12-04
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Arthrocare, Arthritiscare & Research, PC — Gilbert, Arizona, United States
- SunValley Arthritis Center, Ltd. — Peoria, Arizona, United States
- CHI St. Vincent Medical Group Hot Springs — Hot Springs, Arkansas, United States
- Med Investigations, Inc — Fair Oaks, California, United States
- HCP Clinical Research, LLC — Huntington Beach, California, United States
- Sierra Rheumatology — Roseville, California, United States
- Pacific Arthritis Center Medical Group — Santa Maria, California, United States
- Robin K. Dore, MD, Inc. — Tustin, California, United States
- Inland Rheumatology and Osteoporosis Medical Group — Upland, California, United States
- Inland Rheumatology Clinical Trials, Inc. — Upland, California, United States
- Desert Valley Medical Group — Victorville, California, United States
- AARDS Research Inc — Aventura, Florida, United States
- RASF-Clinical Research Inc — Boca Raton, Florida, United States
- Omega Research Consultants — DeBary, Florida, United States
- University of Florida College of Medicine - Jacksonville - Rheumatology Research — Jacksonville, Florida, United States
- University of Florida, Rheumatology at ACC — Jacksonville, Florida, United States
- Center for Arthritis and Rheumatic Diseases — Miami, Florida, United States
- Jeffrey Alper, MD — Naples, Florida, United States
- Medallion Clinical Research Institute, LLC — Naples, Florida, United States
- Suncoast Clinical Research, Inc. — New Port Richey, Florida, United States
- Florida Arthritis & Osteoporosis Center — Port Richey, Florida, United States
- Gulf Coast Medical Center — Port Richey, Florida, United States
- West Broward Rheumatology Associates, Inc. — Tamarac, Florida, United States
- USF Health Morsani Center for Advanced Healthcare — Tampa, Florida, United States
- Rheumatology Associates of North Alabama, PC — Huntsville, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.